Griebel, Guy
Sanofi (France)
18 papers on CoChatORCID 0000-0002-6052-9438
Most cited papers
- Verified
Measuring normal and pathological anxiety-like behaviour in mice: a review
Belzung, C., & Griebel, G. (2001) · Behavioural Brain Research
Neurotransmitter Receptor Influence on BehaviorAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 912
- Verified
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal
Surget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., Hen, R., & Belzung, C. (2008) · Biological Psychiatry
Neurogenesis and neuroplasticity mechanismsStress Responses and Cortisol
Cited by 556
- Verified
Antidepressants recruit new neurons to improve stress response regulation
Surget, A., Tanti, A., Leonardo, E. D., Laugeray, A., Rainer, Q., Touma, C., Palme, R., Griebel, G., Ibarguen-Vargas, Y., Hen, R., et al. (2011) · Molecular Psychiatry
Neurogenesis and neuroplasticity mechanismsStress Responses and Cortisol
Cited by 471
- Verified
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
Griebel, G., Simiand, J., Serradeil-Le Gal, C., Wagnon, J., Pascal, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · Proceedings of the National Academy of Sciences
Neuropeptides and Animal PhysiologyNeuroendocrine regulation and behavior
Cited by 471
- Verified
The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic
Blanchard, D. C., Griebel, G., & Blanchard, R. J. (2003) · European Journal of Pharmacology
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMemory and Neural Mechanisms
Cited by 295
- Verified
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)
Cohen, C., Perrault, G., Griebel, G., & Soubrié, P. (2005) · Neuropsychopharmacology
Smoking Behavior and CessationCannabis and Cannabinoid Research
Cited by 251
- Verified
Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist
Gal, C. S.-L., Wagnon, J., Simiand, J., Griebel, G., Lacour, C., Guillon, G., Barberis, C., Brossard, G., Soubrié, P., Nisato, D., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics
Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology
Cited by 211
- Verified
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery
Neuropeptides and Animal PhysiologyNeuroendocrine regulation and behavior
Cited by 194
- Verified
Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415
Stemmelin, J., Lukovic, L., Salome, N., & Griebel, G. (2005) · Neuropsychopharmacology
Neurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal Physiology
Cited by 112
- Verified
The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents
Griebel, G., Stemmelin, J., Lopez-Grancha, M., Boulay, D., Boquet, G., Slowinski, F., Pichat, P., Beeské, S., Tanaka, S., Mori, A., et al. (2019) · Scientific Reports
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 97
- Verified
Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats
Salomé, N., Stemmelin, J., Cohen, C., & Griebel, G. (2006) · Psychopharmacology
Neuropeptides and Animal PhysiologyNeurotransmitter Receptor Influence on Behavior
Cited by 89
- Verified
The Vasopressin V1bReceptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies
Griebel, G., Beeské, S., & Stahl, S. M. (2012) · The Journal of Clinical Psychiatry
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 81
- Verified
The vasopressin V1b receptor as a therapeutic target in stress-related disorders
Griebel, G., Simiand, J., Stemmelin, J., Gal, C., & Steinberg, R. (2003) · Current Drug Target -CNS & Neurological Disorders
Neuropeptides and Animal PhysiologyStress Responses and Cortisol
Cited by 74
- Verified
Evidence that the Behaviors in the Mouse Defense Test Battery Relate to Different Emotional States: A Factor Analytic Study
GRIEBEL, G., BLANCHARD, D. C., & BLANCHARD, R. J. (1996) · Physiology & Behavior
Memory and Neural MechanismsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 72
- Verified
SL651498: An Anxioselective Compound with Functional Selectivity for α2- and α3-Containing γ-Aminobutyric AcidA (GABAA) Receptors
Griebel, G., Perrault, G., Simiand, J., Cohen, C., Granger, P., Decobert, M., Françon, D., Avenet, P., Depoortere, H., Tan, S., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics
Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling
Cited by 59
- Verified
Acute inescapable stress exposure induces long-term sleep disturbances and avoidance behavior: a mouse model of post-traumatic stress disorder (PTSD)
Philbert, J., Pichat, P., Beeské, S., Decobert, M., Belzung, C., & Griebel, G. (2011) · Behavioural Brain Research
Sleep and Wakefulness ResearchPosttraumatic Stress Disorder Research
Cited by 57
- Verified
Impaired memory following predatory stress in mice is improved by fluoxetine
El Hage, W., Peronny, S., Griebel, G., & Belzung, C. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Memory and Neural MechanismsPosttraumatic Stress Disorder Research
Cited by 28
- Verified
The CRF1 receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: Comparison with paroxetine and d-cycloserine
Philbert, J., Beeské, S., Belzung, C., & Griebel, G. (2015) · Behavioural Brain Research
Posttraumatic Stress Disorder ResearchSleep and Wakefulness Research
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free